13 October 2021 - The debate in Congress over negotiating drug prices is based on a phony premise that higher prices are needed to fund pharmaceutical R&D.

America is the undisputed global leader in drug research and development, and pharmaceutical companies warn that imposing controls on drug prices — like those currently being debated in Congress — will stifle that innovation. But many Americans, including the well insured, cannot afford the innovative drugs produced by that research.

Read Politico article